114 related articles for article (PubMed ID: 17976862)
1. Aging effects on the dopamine transporter expression and compensatory mechanisms.
Cruz-Muros I; Afonso-Oramas D; Abreu P; Pérez-Delgado MM; Rodríguez M; González-Hernández T
Neurobiol Aging; 2009 Jun; 30(6):973-86. PubMed ID: 17976862
[TBL] [Abstract][Full Text] [Related]
2. Deglycosylation and subcellular redistribution of VMAT2 in the mesostriatal system during normal aging.
Cruz-Muros I; Afonso-Oramas D; Abreu P; Rodríguez M; González MC; González-Hernández T
Neurobiol Aging; 2008 Nov; 29(11):1702-11. PubMed ID: 17582657
[TBL] [Abstract][Full Text] [Related]
3. The dopamine transporter is differentially regulated after dopaminergic lesion.
Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Álvarez de la Rosa D; Castro-Hernández J; Salas-Hernández J; Giráldez T; González-Hernández T
Neurobiol Dis; 2010 Dec; 40(3):518-30. PubMed ID: 20688165
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
[TBL] [Abstract][Full Text] [Related]
5. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
[TBL] [Abstract][Full Text] [Related]
6. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
[TBL] [Abstract][Full Text] [Related]
7. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
8. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
9. Bupropion increases striatal vesicular monoamine transport.
Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
11. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system.
Barroso-Chinea P; Cruz-Muros I; Afonso-Oramas D; Castro-Hernández J; Salas-Hernández J; Chtarto A; Luis-Ravelo D; Humbert-Claude M; Tenenbaum L; González-Hernández T
Neurobiol Dis; 2016 Apr; 88():44-54. PubMed ID: 26777664
[TBL] [Abstract][Full Text] [Related]
12. Different effect of age on dopamine transporters in the dorsal and ventral striatum of controls and alcoholics.
Tupala E; Hall H; Bergström K; Mantere T; Räsänen P; Särkioja T; Hiltunen J; Tiihonen J
Synapse; 2003 Jun; 48(4):205-11. PubMed ID: 12687640
[TBL] [Abstract][Full Text] [Related]
13. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
[TBL] [Abstract][Full Text] [Related]
14. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
Volz TJ; Kim M; Schenk JO
Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in dopamine- and vesicular monoamine-transporter functions.
Dluzen DE; McDermott JL
Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects and mechanisms of action of mercuric chloride on striatal dopamine release by using in vivo microdialysis in freely moving rats.
Vidal L; Alfonso M; Faro LF; Campos F; Cervantes R; Durán R
Toxicology; 2007 Jul; 236(1-2):42-9. PubMed ID: 17481795
[TBL] [Abstract][Full Text] [Related]
17. Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments.
Cruz-Muros I; Afonso-Oramas D; Abreu P; Barroso-Chinea P; Rodríguez M; González MC; Hernández TG
Exp Neurol; 2007 Mar; 204(1):147-61. PubMed ID: 17112516
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter.
Moy LY; Wang SP; Sonsalla PK
J Pharmacol Exp Ther; 2007 Feb; 320(2):747-56. PubMed ID: 17090704
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of dopamine and serotonin transporters associated with the pathophysiologic mechanism of Tourette syndrome.
Jijun L; Zaiwang L; Anyuan L; Shuzhen W; Fanghua Q; Lin Z; Hong L
Neurol India; 2010; 58(4):523-9. PubMed ID: 20739786
[TBL] [Abstract][Full Text] [Related]
20. Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.
Adkins EM; Samuvel DJ; Fog JU; Eriksen J; Jayanthi LD; Vaegter CB; Ramamoorthy S; Gether U
Biochemistry; 2007 Sep; 46(37):10484-97. PubMed ID: 17711354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
